We have previously shown that the PLAG1 gene on chromosome 8q12 is consistently rearranged in pleomorphic adenomas of the salivary glands with t(3;8)(p21;q12) translocations. The t(3;8) results in promoter swapping between the PLAG1 gene, which encodes a novel zinc ®nger protein, and the constitutively expressed gene for b-catenin (CTNNB1), a protein with roles in cell-cell adhesion and the WG/WNT signalling pathway. In order to assess the importance of other translocation partner genes of PLAG1, and their possible relationship to CTNNB1, we have characterized a second recurrent translocation, i.e. the t(5;8)(p13;q12). This translocation leads to ectopic expression of a chimeric transcript consisting of sequences from the ubiquitously expressed gene for the leukemia inhibitory factor receptor (LIFR) and PLAG1. As for the t(3;8), the fusions occurred in the 5'-noncoding regions of both genes, exchanging regulatory control elements while preserving the coding sequences. The results of the current as well as previous studies indicate that ectopic expression of PLAG1 under the control of promoters of distinct translocation partner genes is a general pathogenetic mechanism for pleomorphic adenomas with 8q12 aberrations.
Introduction
In recent years, insight has been obtained in the genetics of pleomorphic adenomas of the salivary glands. Extensive cytogenetic studies have revealed a highly speci®c pattern of chromosomal abnormalities (Sandros et al., 1990; Bullerdiek et al., 1993) . In addition to a large group of adenomas with a normal stemline (about 30%), there are several subgroups characterized by mainly structural deviations and, in particular, reciprocal translocations. The largest subgroup is characterized by rearrangements involving band 8q12 (about 39%). Of these cases approximately 41% show a speci®c t(3;8)(p21;q12) translocation. The remaining cases demonstrate a variety of other structural rearrangements with involvement of a large number of translocation partners. The second subgroup, which is the smallest (about 8%), comprises cases with an involvement of 12q13-15. A few tumours of this subgroup show a speci®c t(9;12)(p13-22;q13-15) translocation. The last subgroup consists of sporadic cases without involvement of either 8q12 or 12q13-15 (about 23%). Recently, the genes aected by the three most frequently rearranged chromosome regions in pleomorphic acdenomas, i.e. 3p21, 8q12, and 12q13-15, have been identi®ed. The gene on chromosome 12q13-15 is the high mobility group protein gene HMGIC. This gene may be considered as a common genetic denominator in benign tumor development since it is also rearranged in a variety of benign mesenchymal tumours (Schoenmakers et al., 1995b; Ashar et al., 1995) . As a result of the chromosomal aberrations, the three DNA binding domains of HMGIC are often separated from the acidic carboxy-terminal tail. Various genes have been found as translocation partners of HMGIC, but their precise role remains to be established. The gene on chromosome 8q12 is a novel, developmentally regulated zinc ®nger gene, designated PLAG1 (Kas et al., 1997) . The PLAG1 protein contains seven amino-terminal C 2 H 2 zinc ®ngers and a serine-rich carboxy-terminus, suggesting that it may act as a transcriptional regulator. The t(3;8)(p21;q12) translocation results in promoter swapping between PLAG1 and the constitutively expressed gene for b-catenin (CTNNB1), a protein interface functioning in adherens junctions and in the WG/WNT signalling pathway (reviewed by Peifer, 1997) . The fusions occur in the 5' noncoding regions of both genes, exchanging regulatory control elements while preserving the coding sequences. Due to the translocation, expression of PLAG1 is upregulated while the expression level of CTNNB1 is reduced about twofold (Kas et al., 1997) . Although PLAG1 seems to be a crucial genetic factor in salivary gland tumorigenesis a concomitant role of b-catenin might also be expected since CTNNB1 is the preferential translocation partner of PLAG1. Recent studies have also ®rmly established the involvement of b-catenin in a variety of other tumour types (reviewed by Peifer, 1997) .
As an approach to assess the importance of the translocation partner genes of PLAG1, we have now characterized a second recurrent translocation, i.e. the t(5;8)(p13;q12). Using Northern blot analysis, the expression of the PLAG1 gene was studied in two pleomorphic adenomas with 5;8-translocations. RNase protection assays were performed to gain insight into the structure of the PLAG1 transcripts, revealing the chimeric nature of the transcripts. The ectopic sequences of the chimeric transcripts were obtained and characterized by 5'-RACE analysis and nucleotide sequence analyses. As a result, a new translocation partner of PLAG1 was identi®ed, i.e. the gene for the leukemia inhibitory factor receptor (LIFR), which has previously been mapped to 5p12-p13 (Gearing et al., 1991 . We demonstrate that the expression of the PLAG1 gene is upregulated in the two pleomorphic adenomas with 5;8-translocations.
Results
Northern blot analysis of PLAG1 gene expression in pleomorphic adenomas with 5;8-translocations
To evaluate the eects of the 5;8-translocation on the expression levels of the PLAG1 gene, we performed Northern blot analysis of RNA from two pleomorphic adenomas with dierent 5;8-translocations as well as from normal salivary gland tissue (Figure 1 ). Using a 3.7 kb PLAG1 cDNA probe, a transcript of about 7.5 kb was detected in tumours C904 and C895 (lanes 3 and 4), whereas this transcript was not detected in normal salivary gland tissue (lane 2). Quanti®cation of the data using a phosphorimager revealed that the expression was two to six times higher in the tumours compared to the fetal kidney cell line 293 (ATCC CRL 1573) which was used as a positive control (lane 1).
RNase protection analysis of the 7.5 kb transcript in adenoma C895
To gain further insight into the structure of the 7.5 kb transcript detected by Northern blot analysis, we compared the PLAG1 mRNA in adenoma C895 to that in normal salivary gland tissue using RNase protection assays (Figure 2) . To detect the predominant PLAG1 transcript, we used a riboprobe representing the noncoding exons 1 and 3 of PLAG1 (riboprobe b), since exon 2 is only found in about one third of the transcripts as a result of alternative Characterization of the 7.5 kb chimeric transcript expressed in adenoma C895
To determine the composition of the chimeric transcript observed in adenoma C895, 5'-RACE experiments were performed. Subsequent nucleotide sequence analysis of the PCR products revealed that ectopic sequences were fused to the acceptor splice site of exon 3 of PLAG1 (see Figure 3 ). BLAST analysis of the ectopic sequences showed that they were identical to sequences of the ®rst exon of the gene for the leukemia inhibitory factor receptor (LIFR) (Gearing et al., 1991) . LIFR has previously been mapped to chromosome 5p12-13 . Since the ®rst exon of LIFR is noncoding, the consequence of the 5;8-translocation is the generation of a LIFR/ PLAG1 fusion gene which is expressed under control of the LIFR promoter, and which retains the complete PLAG1 coding region (the ATG of PLAG1 resides in exon 4, Figure 3 ).
The 5;8-translocation involving PLAG1 and LIFR is recurrent
To determine whether the 5;8-translocation involving the PLAG1 and LIFR genes is recurrent, RT ± PCR experiments were performed using RNA from a second adenoma with a 5;8-translocation, i.e. adenoma C904, as well as RNA from adenoma C895 and normal salivary gland tissue as controls. Ampli®cations performed with primers speci®c for exon 1 of LIFR and exon 4 of PLAG1 gave rise to a main ampli®cation product of 474 bp in the two tumours, consistent with a transcript containing exon 1 of LIFR fused to exons 3 and 4 of PLAG1 (Figure 3c , panel 1, lanes 2 and 3). As expected, no chimeric transcript was detected in normal salivary gland tissue ( Figure 3c , panel 1, lane 1). A PCR product of 579 bp was also observed in both tumours. This product contains an extra 105 bp which corresponds to the alternatively spliced exon 2 of PLAG1, indicating that in both tumours, the breakpoints had occurred in the ®rst intron of PLAG1. The identity of the dierent PCR products was con®rmed by nucleotide sequence analysis. The reciprocal fusion transcript PLAG1/ LIFR could not be detected in any of the tumours, not even after multiple rounds of PCR (data not shown). The normal transcripts for LIFR and PLAG1 corresponding to the unaected alleles were detected in both tumours as well as in normal salivary gland tissue ( Figure 3c , panels 2 and 3). Note the alternatively spliced PLAG1 isoforms with (541 bp) and without (436 bp) exon 2 (Figure 3c, panel 3) .
Northern blot analysis of the expression patterns of the LIFR and PLAG1 genes Expression of the human LIFR gene was determined by Northern blot analysis of RNA from fetal and adult tissues (Figure 4 , panel a) and compared to the expression pattern of the PLAG1 transcript (Figure 4 , panel c). A complex and heterogeneous pattern of expression was observed for the LIFR gene. A major transcript of 10 kb corresponding to the full length mRNA was detected in most tissues while minor transcripts with approximate molecular sizes of 8, 6 and 2 kb, respectively, were found to be dierentially expressed. These smaller products probably correspond to various alternatively spliced mRNAs as described for the murine Lifr gene (Owczarek et al., 1994) . It should be noted that LIFR is also expressed in normal salivary gland tissue (Figure 4, panel a, lane 13) . The ubiquitous expression of LIFR [longer exposure of the ®lm revealed the presence of four transcripts also in lung (lane 8) and liver (lane 9)] contrasts with the developmentally regulated expression of PLAG1, expression of which was detected only in fetal tissues such as lung, liver, kidney and placenta (Figure 4 , panel c, lanes 2, 3, 4, and 7).
FISH analysis of the 5p13 and 8q12 translocation breakpoints
To obtain independent evidence of the involvement of the LIFR and PLAG1 genes in the 5;8-translocations, we hybridized YACs containing the LIFR or the PLAG1 gene to metaphase chromosomes from adenoma C904 (there was no material available for FISH analysis from adenoma C895). Cytogenetic analysis of metaphase chromosomes of C904 revealed a complex t(1;5;8)(p31;p13;q12) translocation, with the 5p13→pter segment translocated to 8q12, the 8q12→qter segment to 1p31, and the 1p31→pter segment to 5p13 ( Figure 5A ). Two dierent LIFRcontaining YACs were isolated (806F9 and 906F4). Figure 4 Northern blot analysis of the expression patterns of the LIFR and PLAG1 genes. Northern blots containing 2 mg of poly(A)-selected RNA of a variety of human fetal tissues, including brain (1), lung (2), liver (3), kidney (4), normal adult tissues, including heart (5), brain (6), placenta (7), lung (8), liver (9), skeletal muscle (10), kidney (11), pancreas (12), as well as 20 mg of total RNA from normal human salivery gland tissue (13) were hybridized to a probe speci®c for LIFR (panel a), to a probe speci®c for PLAG1 (panel c), or an actin probe (panels b and d).
The positions of the RNA size markers are indicated Both YACs were shown to span the 5p13 translocation breakpoint, since hybridization signals were observed on both the der(5) and der(8) chromosomes ( Figure  5B ). Similarly, hybridization with a PLAG1-containing YAC (166F4) (RoÈ ijer et al., 1996; Kas et al., 1997) revealed a breakpoint within the PLAG1 gene. According to the cytogenetic analysis, the 8q12-qter segment is translocated to 1p31 ( Figure 5A ) and consequently hybridization signals should be expected on the der(1) and der(8) chromosomes. However, FISH analysis revealed a hidden translocation of 8q12 sequences to 5p13 since signals from the PLAG1-containing YAC were found on both the der(5) and der(8) chromosomes ( Figure 5C ). Our FISH analysis thus con®rms that both the LIFR and PLAG1 genes are disrupted by the 5;8-translocations in pleomorphic adenomas.
Discussion
In the current study, we demonstrate that in pleomorphic adenomas with t(5;8) translocations, or variants thereof, the LIFR gene is a recurrent translocation partner of the PLAG1 gene, which is the gene consistently rearranged in adenomas with chromosome 8q12 involvement (Kas et al., 1997) . The translocations lead to upregulation of PLAG1 gene expression under control of the LIFR promoter. LIFR is the second translocation partner known for PLAG1; the ®rst one being the CTNNB1 gene, which is the translocation partner gene in adenomas with t(3;8)(p21;q12). The LIFR gene encodes the receptor for the leukemia inhibitory factor (LIF) (Gearing et al., 1991) , a multi-functional member of the interleukin-6 (IL-6) cytokine family, which is involved in differentiation, survival, and proliferation of a wide variety of fetal and adult cells (reviewed by Gearing, 1993) . Structurally, LIFR is a member of the hemopoietin family of receptors (Bazan, 1990; Cosman et al., 1990) . Recently, the gemomic organization of the human LIFR gene was described (Tomida and Gotoh, 1996) . The gene covers more than 70 kb of genomic DNA and contains 20 exons (cf. Figure 3b) . The breakpoints in both adenomas occurred in the ®rst intron of LIFR, which spans about 23 kb and is the largest one of the gene. The LIFR promoter contains a consensus TATA motif located about 30 bp upstream of the transcription initiation site as well as sequence binding motifs for other regulatory elements such as the transcription factors AP-2 and Sp1. The LIFR promoter is active in a wide variety of fetal and adult tissues, including normal salivary gland tissue as demonstrated by Northern blot analysis. A similar expression pattern has also been noted for the murine Lifr gene (Owczarek et al., 1994) . In contrast, the expression of PLAG1 was restricted to fetal tissues and could not be detected in adult salivary gland tissue by Northern blot analysis (Kas et al., 1997) . It should be noted, however, that PLAG1 expression could be detected in adult tissues by more sensitive assays such as RNase protection or RT ± PCR (but only after two rounds), indicating a very low expression level (see Figure 3c, panel 3) . Thus, the net result of the 5;8-translocations is that PLAG1 becomes regulated by the LIFR promoter, leading to increased PLAG1 expression. A similar mechanism has also been found in adenomas with t(3;8)(p21;q12) or t(8;15)(q12;q14) translocations. In these cases, PLAG1 regulatory elements were found to be exchanged by those of the gene encoding b-catenin or the translocation partner gene on 15q14, which remains to be identi®ed. However, in the case of the t(3;8), the reciprocal fusion transcript (PLAG1/CTNNTB1), consisting of exon 1 of PLAG1 and exons 2 to 16 of CTNNB1, was found in all but two tumours (Kas et al., 1997) . In the present cases with t(5;8), no reciprocal PLAG1/LIFR transcript could be detected, not even after multiple rounds of PCR, whereas the normal PLAG1 and LIFR transcripts were detected in both tumours (see Figure 3c , panels 2 and 3), suggesting that additional rearrangements of the der(5) chromosome might have occurred. The observation that in two dierent cytogenetic subgroups of adenomas structurally unrelated genes, CTNNB1 and LIFR, act as translocation partner of PLAG1 suggests that it is the exchange of regulatory regions that is critical and that promoter swapping (or, in this study, substitution) of PLAG1 is a general pathogenetic mechanism in pleomorphic adenomas with 8q12 involvement. Available cytogenetic data suggest that a relatively large number of translocation partner genes of PLAG1 are likely to be found. An intriguing question pertains to the role of the PLAG1 gene in salivary gland tumorigenesis. PLAG1 encodes a novel zinc ®nger protein with seven C2H2 zinc ®ngers in its amino-terminal region and a serinerich domain in its carboxy-terminal region (Kas et al., 1997) . These structural features suggest that PLAG1 may be involved in regulation of gene expression. Preliminary experiments have recently indicated that the PLAG1 protein indeed binds to DNA in a speci®c manner, and that it possesses a strong activator domain (Kas et al., to be published elsewhere), supporting this possibility. Ectopic expression of PLAG1 could thus lead to deregulation of particular target genes and consequently to loss of important cell proliferation control mechanisms.
Another crucial question in this context is whether the role of the dierent translocation partner genes is limited to providing a strong promoter to the PLAG1 gene. On the basis of its frequent involvement in pleomorphic adenomas as well as in various other tumours (Ilyas and Tomlinson, 1997) , a possible synergistic eect has been suggested for the CTNNB1 gene, the translocation partner gene of PLAG1 in pleomorphic adenomas with t(3;8)(p21;q12) (Kas et al., 1997) . It is tempting to speculate that the role of b-catenin in determining cell fate during embryogenesis (reviewed by Eaton and Cohen, 1996) might be a relevant factor. Interestingly, b-catenin and LIFR show several functional similarities, i.e. they are both involved in dierentiation, survival, and proliferation of fetal and adult cells (reviewed by Gearing, 1993) . Whether these shared features are critical remains, however, to be established. Tumour-associated changes in expression levels of b-catenin have been reported before (see Ilyas and Tomlinson, 1997) while, to our knowledge, the present study provides the ®rst link of LIFR to tumorigenesis.
Materials and methods

Tumour material and cytogenetic analysis
Two pleomorphic adenomas with 5;8-translocations were selected for molecular analysis. Both were primary tumours originating from the parotid gland in previously untreated patients. Chromosome preparations were made from shortterm primary cultures as previously described (RoÈ ijer et al., 1996) . Tumour C895 had a t(5;8)(p13;q12) translocation as the sole abnormality, while C904 had a complex t(1;5;8)(p31;p13;q12) translocation as the sole abnormality ( Figure 5A ).
Preparation and analyses of RNA
Total RNA was extracted from biopsy samples using TRIZOL (GIBCO/BRL) according to the supplier's protocol. Northern blot analysis was performed according to standard procedures (Sambrook et al., 1989) . To study the expression pattern of the LIFR and PLAG1 genes, Multiple Tissue Northern blots (Clontech) were used following the manufacturer's protocol. For ®lter hybridizations, probes were radio-labelled with a-32 P-dCTP using random hexamers (Feinberg and Vogelstein, 1984) . The PLAG1 probe was a 3.7 kb EcoRI cDNA fragment of PLAG1 containing 438 bp of the 5'-UTR, the complete coding region, and approximately 1800 bp of the 3'-UTR. The LIFR probe was generated by PCR and contained nucleotides 35 to 2039 of the published cDNA sequence (Gearing et al., 1991) . The actin probe used as internal control was a 2.0 kb human b-actin cDNA probe (Clontech).
RNase protection assays
Plasmids containing the probe templates were linearized by digestion with an appropriate restriction enzyme at the 5'-ends of the inserts. The antisense riboprobes were transcribed from the downstream bacteriophage promoter (either the T7 or Sp6 promoter) in the presence of 12.5 mM of a-32 P-UTP (800 Ci/mmol, Amersham) and 25 mM of cold rUTP, in the case of riboprobes b and c (see Figure 2) , and in presence of 3.75 mM of a-32 P-UTP and 500 mM of cold rUTP, in case of riboprobe a. Gelpuri®ed probe (*5610 5 c.p.m. for riboprobe b and c and 2610 5 c.p.m. for riboprobe a) was annealed to 5 mg of total RNA in 30 ml hybridization buer (80% (v/v) formamide, 40 mM PIPES, 400 mM NaCl, 1 mM EDTA) overnight at 458C and subsequently digested with a mixture of RNase A (15 mg/ml ®nal concentration) and RNase T1 (88 U/ml ®nal concentration) (both GIBCO/ BRL) at 378C for 30 min. The digestions were terminated by adding SDS to a ®nal concentration of 0.5%, and proteinase K to 125 mg/ml, and by incubating the samples at 378C for an additional 15 min. After a phenolchloroform extraction, the protected riboprobes were puri®ed by ethanol precipitation, resuspended in 80% (v/v) formamide, and analysed by electrophoresis using a 5% polyacrylamide gel containing 7 M urea. End-labelled Msp1 fragments of pcDNA3 (Invitrogen) were also loaded on the gel to serve as single-strand molecular weight markers.
Rapid ampli®cation of 5' cDNA ends (5'-RACE) and nucleotide sequence analysis For 5'-RACE experiments, the Marathon cDNA Amplification kit (Clontech) was used according to the manufacturer's instructions with minor modi®cations. First strand cDNA was synthesized from 5 mg total RNA using the MV2-low primer (5'-CTG CAC TTG ACC CAC CCC TTG GAT-3') located in exon 5 of PLAG1. The ds cDNA was ligated to the Marathon cDNA adaptor and ampli®ed using the adaptor primer AP1 and the MV5 primer (5'-CAG GAG AAT GAG TAG CCA TGT GCC-3') also located in exon 5 of PLAG1. A second round of PCR was performed using the adaptor primer AP2 and the MV6 primer (5'-GC ACT TGT AGG GCC TCT CTC CTG-3') located in exon 4 of PLAG1. The ®nal PCR products were puri®ed from agarose gels and cloned into the pCR2.1 vector (Invitrogen). The nucleotide sequences were determined according to the dideoxy chain termination method using the T7 polymerase sequencing kit of Pharmacia/LKB and were analysed using an A.L.F. DNA sequencer TM (Pharmacia Biotech). Sequence analysis was performed using Lasergene (DNASTAR) and BLAST searches (NCBI).
RT ± PCR
Total RNA (5 mg) was reverse-transcribed using Superscript II reverse transcriptase (GIBCO/BRL) and oligod(T) primers according to the recommended conditions. An aliquot of 0.25 mg of the resulting ®rst strand cDNA was ampli®ed using a variety of primer sets. The ampli®cation conditions for the LIFR/PLAG1 fusion transcript were 30 cycles at 948C for 10 s, and 688C for 20 s and 728C for 40 s in a ®nal volume of 50 ml using the AmpliTaq PCR system (Perkin Elmer). The ®rst round PCR was carried out with the LIFR primer 5'-AGA ACG TGT CTC TGC TGC AAG GC-3' (LIFR-NUP; sequences from exon 1 of LIFR) and the PLAG1 primer 5'-CAG GAG AAT GAG TAG CCA TGT GCC-3' (MV5; sequences from exon 5 of PLAG1). The second round of PCR was performed on a 20-fold diluted sample with the LIFR primer 5'-CAU CAU CAU -CAU CTC CTA ATC CCA GCT CAG AAA GG -3' (LIFR-CAU; sequences from exon 1 of LIFR) and the PLAG1 primer 5'-GC ACT TGT AGG GCC TCT CTC CTG-3' (MV6; sequences from exon 4 of PLAG1). The normal transcripts of LIFR were detected after two rounds of PCR. The ®rst round was carried out with the LIFR-NUP primer and the primer 5'-TGT TCC AGA GGG TGC TTT CCA AG-3' (LIF397AS; sequences from exon 3 of LIFR) and the second round with the primer LIFR-CAU and the primer 5'-CAT GAG GAG CCC CCT TTT TCT GG-3' (LIF332AS; sequences from exons 2 and 3 of LIFR). The normal transcripts of PLAG1 were detected after two rounds of PCR. The ®rst round was carried out with the primer 5'-CAA TGG CTG GAA AGA GG-3' (START-UP; sequences from exon 1 of PLAG1) and MV5 and the second one with the primer 5'-GGC CGG AGG GAG GAT GTT AA-3' (START-RACE; sequences from exon 1 of PLAG1) and MV6. The identities of the PCR products were con®rmed by nucleotide sequence analysis.
Isolation of YAC clones and FISH analyses
LIFR YAC clones were isolated from the CEPH mark 3 YAC library (Chumakov et al., 1992) by a combination of PCR-based screening and colony hybridization analysis (Green and Olson, 1990 ) using the primer set LIFR-NUP and LIFR-low (5'-TGG AGG GCG ATG AAT GAG TCG C-3'). YAC DNA was isolated and characterized as described before (Schoenmakers et al., 1994 (Schoenmakers et al., , 1995a . For FISH analysis, YAC DNAs were ampli®ed by Inter-Alu-PCR and labelled with biotin-16-dUTP (Boehringer Mannheim), and subsequently cohybridized with alphasatellite probes for chromosomes 5 and 8 (the chromosome 5 probe also detects chromosomes 1 and 19) (Oncor), as previously described (RoÈ ijer et al., 1996) .
